Target intelligence / Profile preview

Innate immune signaling in epithelial and dendritic cells

Molecular classification
Other
01

Overview

Innate immune signaling in epithelial and dendritic cells is a coordinated biological process essential for maintaining mucosal homeostasis and initiating host defense (Swamy et al., 2010, Nature Immunology). Epithelial cells function as the primary sensors of the environment, utilizing pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) to detect microbial-associated molecular patterns (MAMPs) and initiate signaling cascades (Akira et al., 2006, Cell). Upon activation, these cells release signaling molecules such as cytokines (e.g., TSLP, IL-33) and chemokines that recruit and instruct dendritic cells (DCs), the professional antigen-presenting cells of the immune system (Holgate, 2012, Clinical & Experimental Allergy). The DCs then process antigens and migrate to lymphoid tissues to activate the adaptive immune system, forming a critical bridge between innate and acquired immunity. Dysregulation of this signaling axis is central to the pathogenesis of chronic inflammatory conditions like asthma, inflammatory bowel disease, and psoriasis (Geremia et al., 2014, Nature Reviews Gastroenterology & Hepatology). Therapeutic interventions often target specific components of this pathway, such as TNF-alpha or IL-23, to dampen pathological inflammation (Neurath, 2014, Nature Reviews Immunology). Understanding this crosstalk is vital for developing precision medicines that can restore immune homeostasis without causing broad immunosuppression.

Other names
Epithelial-dendritic cell axisMucosal innate immune signalingInnate immune crosstalkEpithelial-DC signaling pathway
02

Mechanism of action

Modulation of the innate-adaptive immune interface through the inhibition of pro-inflammatory cytokines, pattern recognition receptor signaling, or downstream Janus kinase (JAK) pathways.

03

Biological functions

Immune responseSignal transductionCell-cell communicationPathogen recognitionCytokine production
04

Disease associations

InflammationInfectionAutoimmune diseaseAllergyCancer
05

Safety considerations

Increased susceptibility to opportunistic infectionsReactivation of latent tuberculosisImpaired mucosal barrier repairPotential for malignancy with long-term immunosuppression
06

Interacting drugs

Infliximab

5 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)C-reactive protein (CRP)CD80/CD86 expression on dendritic cellsThymic stromal lymphopoietin (TSLP)

Beyond the preview

Go deeper on Innate immune signaling in epithelial and dendritic cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune signaling in epithelial and dendritic cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call